Literature DB >> 8426404

Long-term results with vacuum constriction device.

M S Cookson1, P W Nadig.   

Abstract

From November 1985 to April 1990, 216 consecutive patients were treated with the vacuum constriction device. Patients were mailed an initial questionnaire (group 1) and a long-term questionnaire (group 2) at a median followup of 3 and 29 months, respectively. Of 202 available patients 161 in group 1 (75%) and 115 in group 2 (57%) responded. Regular use of the vacuum constriction device was reported by 69% group 1 and 70% group 2 patients. patient and partner satisfaction was 82% and 87% in group 1, and 84% and 89% in group 2, respectively. There were no significant differences between the groups with respect to regular use and patient or partner satisfaction (p < 0.05). Quality of erection was evaluated for hardness, length and circumference, and with satisfaction greater than 90% in both groups. Median times per month of successful intercourse were 1, 4 and 4 for the year before, during and after obtaining the vacuum constriction device in group 2. Also, 79% of the patients in group 2 reported a statistically significant increase in the frequency of intercourse per month in the first year, which was sustained beyond the first year in 77% (p < 0.01). Our results support the efficacy of the vacuum constriction device for the treatment of impotence. Overall regular use rates as well as patient and partner satisfaction appear to be high. Furthermore, excellent initial results appear durable in most patients.

Entities:  

Mesh:

Year:  1993        PMID: 8426404     DOI: 10.1016/s0022-5347(17)36059-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  23 in total

1.  [Management of erectile dysfunction after radical prostatectomy. Urologists' assessment vs patient survey responses].

Authors:  K Herkommer; S Niespodziany; C Zorn; J E Gschwend; B G Volkmer
Journal:  Urologe A       Date:  2006-03       Impact factor: 0.639

2.  The role of penile prosthetic surgery in the modern management of erectile dysfunction.

Authors:  S Jain; A Bhojwani; T R Terry
Journal:  Postgrad Med J       Date:  2000-01       Impact factor: 2.401

Review 3.  Economic cost of male erectile dysfunction using a decision analytic model: for a hypothetical managed-care plan of 100,000 members.

Authors:  H L Tan
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

Review 4.  An overview of the diagnosis and treatment of erectile dysfunction.

Authors:  Sivaprakasam Sivalingam; Hashim Hashim; Hartwig Schwaibold
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 5.  Aetiology and management of male erectile dysfunction and female sexual dysfunction in patients with cardiovascular disease.

Authors:  Stephen L Archer; Ferrante S Gragasin; Linda Webster; Derek Bochinski; Evangelos D Michelakis
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 6.  A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?

Authors:  Konstantinos Hatzimouratidis; Dimitrios G Hatzichristou
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 7.  Erectile dysfunction following radical retropubic prostatectomy: epidemiology, pathophysiology and pharmacological management.

Authors:  Kalyana C Nandipati; Rupesh Raina; Ashok Agarwal; Craig D Zippe
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

8.  [Prostate carcinoma and erectile dysfunction. Which therapy when?].

Authors:  H Sperling; J Noldus
Journal:  Urologe A       Date:  2003-10       Impact factor: 0.639

Review 9.  External devices for treatment of erectile dysfunction.

Authors:  Laurence A Levine
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.633

10.  Optimizing postoperative sexual function after radical prostatectomy.

Authors:  Manuela Tutolo; Alberto Briganti; Nazareno Suardi; Andrea Gallina; Firas Abdollah; Umberto Capitanio; Marco Bianchi; Niccolò Passoni; Alessandro Nini; Nicola Fossati; Patrizio Rigatti; Francesco Montorsi
Journal:  Ther Adv Urol       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.